These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13152660)

  • 1. The distribution in the body and metabolic fate of barbiturates.
    RAVENTOS J
    J Pharm Pharmacol; 1954 Apr; 6(4):217-35. PubMed ID: 13152660
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic fate of drugs: barbiturates and closely related compounds.
    Bush MT; Sanders E
    Annu Rev Pharmacol; 1967; 7():57-76. PubMed ID: 5337091
    [No Abstract]   [Full Text] [Related]  

  • 3. On the specificity of penultimate oxidation. The fate of 5-ethyl-5-n-hexylbarbituric acid.
    Maynert EW
    J Pharmacol Exp Ther; 1965 Dec; 150(3):476-83. PubMed ID: 5854854
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of drugs. I. The metabolic fate of ethylhexabital (5-cyclohexenyl-5-ethylbarbituric acid.) (1).
    TSUKAMOTO H; TAKABATAKE E; YOSHIMURA H
    Pharm Bull; 1954 Sep; 2(3):201-5. PubMed ID: 13215037
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of drugs. II. The metabolic fate of ethylhexabital (5-cyclohexenyl-5-ethylbarbituric acid).
    TSUKAMOTO H; YOSHIMURA H; TOKI S
    Pharm Bull; 1955 Aug; 3(4):239-42. PubMed ID: 13289263
    [No Abstract]   [Full Text] [Related]  

  • 6. METABOLIC fate of thiopental sodium.
    J Am Med Assoc; 1951 Oct; 147(9):875-6. PubMed ID: 14873585
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of drugs. VII. The metabolic fate of methylhexabital (5-cyclohexenyl-3, 5-dimethylbarbituric acid). 3. Isolation, characterization, and identification of metabolic products of methylhexabital.
    TOKI S; TSUKAMOTO H; YOSHIMURA H
    Pharm Bull; 1956 Oct; 4(5):368-71. PubMed ID: 13388623
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism of drugs. III. The metabolic fate of methylhexabital (5-cyclohexenyl-3, 5-dimethyl-barbituric acid).
    TSUKAMOTO H; YOSHIMURA H
    Pharm Bull; 1955 Oct; 3(5):397-8. PubMed ID: 13289304
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of drugs. VIII. The metabolic fate of methylhexabital (5-cyclohexenyl-3, 5-dimethylbarbituric acid). 4. Ultraviolet and infrared absorption spectra of the metabolites of MHB and related compounds.
    TOKI S; TSUKAMOTO H; YOSHIMURA H
    Pharm Bull; 1956 Oct; 4(5):371-5. PubMed ID: 13388624
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of drugs. XVII. Metabolic fate of methylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). 7. Separation and identification of biotransformation products of methylhexabital in the urine of rabbits by paper chromatography.
    TSUKAMOTO H; YOSHIMURA H; TOKI S
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):15-8. PubMed ID: 13537142
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of drugs. XVI. The metabolic fate of methylhexabital (5-cyclohexenyl-3,5-dimethylbarbituric acid). 6. Studies on the reduction of 3-keto-MHB (5-(3-oxo-1-cyclohexenyl)-3,5-dimethylbarbituric acid) and on pharmacological activity of the biotransformation products of methylhexabital from the urine of rabbits.
    YOSHIMURA H
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):13-5. PubMed ID: 13537141
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of drugs. XVIII. The metabolic fate of methylhexabital (5-cyclohexenyl-3,5 dimethylbarbituric acid). 8. The quantitative determination of main biotransformation products of methylhexabital in the urine of rabbits by ultra-violet spectrophotometry.
    TSUKAMOTO H; YOSHIMURA H; TOKI S
    Chem Pharm Bull (Tokyo); 1958 Feb; 6(1):88-91. PubMed ID: 13537158
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibitory effects of beta-diethylaminoethyl diphenylpropylacetate on a variety of drug metabolic pathways in vitro.
    COOPER JR; AXELROD J; BRODIE BB
    J Pharmacol Exp Ther; 1954 Sep; 112(1):55-63. PubMed ID: 13192609
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolic investigations of proxibarbal [5-allyl-5-(2-hydroxypropyl)barbituric acid] in vitro.
    Frochaux-Zeidler EL; Testa B
    Pharm Acta Helv; 1980; 55(3):79-82. PubMed ID: 6104818
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2,4,6-trioxoperhydropyrimidine (BCP) in man. IV. Pharmacokinetics of BCP in man following oral administration.
    Yashiki T; Matsuzawa T; Yamada M; Kondo T; Uda Y
    Chem Pharm Bull (Tokyo); 1971 May; 19(5):869-80. PubMed ID: 5557927
    [No Abstract]   [Full Text] [Related]  

  • 16. [Distribution of veronal labeled with C14 in various segments of the brain in rats].
    CHU SP
    Farmakol Toksikol; 1958; 21(6):11-4. PubMed ID: 13619740
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on distribution of veronal in the central nervous system using the method of labeled atoms].
    SHNOL' SE; ZOGRABIAN SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1956; 56(8):654-8. PubMed ID: 13393718
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolism of radioactive labelled barbiturates and thiobarbiturates. I. Excretion of radioactivity].
    BLOCK W; EBIGT I
    Arzneimittelforschung; 1957 Sep; 7(9):572-6. PubMed ID: 13471406
    [No Abstract]   [Full Text] [Related]  

  • 19. [Barbiturates. III. Metabolism of veronal].
    GOLDSCHMIDT S; WEHR R
    Hoppe Seylers Z Physiol Chem; 1957 May; 308(1):9-19. PubMed ID: 13448662
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro metabolism of barbiturates.
    SHIDEMAN FF
    Fed Proc; 1952 Jun; 11(2):640-6. PubMed ID: 14945528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.